ENSG:NSD-The Ensign Group Inc (USD)

COMMON STOCK | Medical Care Facilities |

Last Closing

USD 143.47

Change

-0.79 (-0.55)%

Market Cap

USD 8.23B

Volume

0.29M

Analyst Target

USD 62.50
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

The Ensign Group, Inc. provides skilled nursing, senior living, and rehabilitative services. It operates through two segments: Skilled Services and Standard Bearer. The company's Skilled Services segment engages in the operation of skilled nursing facilities and rehabilitation therapy services for patients with chronic conditions, prolonged illness, and the elderly; and offers nursing facilities including specialty care, such as on-site dialysis, ventilator care, cardiac, and pulmonary management, as well as standard services comprising room and board, special nutritional programs, social services, recreational activities, entertainment, and other services. Its Standard Bearer segment is comprised of selected real estate properties owned by Standard Bearer and leased to skilled nursing and senior living operators. In addition, the company provides ancillary services consisting of digital x-ray, ultrasound, electrocardiograms, sub-acute services, dialysis, respiratory, and long-term care pharmacy and patient transportation to people in their homes or at long-term care facilities, as well as mobile diagnostics. It operates in Arizona, California, Colorado, Idaho, Iowa, Kansas, Nebraska, Nevada, South Carolina, Texas, Utah, Washington and Wisconsin. The company was incorporated in 1999 and is based in San Juan Capistrano, California.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-07 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap
ACHC Acadia Healthcare Company Inc

-0.84 (-1.51%)

USD 5.10B
OPCH Option Care Health Inc

-0.75 (-2.57%)

USD 4.99B
SGRY Surgery Partners Inc

-1.05 (-3.37%)

USD 3.96B
AMED Amedisys Inc

-0.30 (-0.31%)

USD 3.14B
ASTH Astrana Health Inc

-0.57 (-0.95%)

USD 2.71B
LFST Lifestance Health Group Inc

-0.24 (-3.47%)

USD 2.64B
ADUS Addus HomeCare Corporation

-1.59 (-1.26%)

USD 2.26B
AVAH Aveanna Healthcare Holdings In..

-0.31 (-6.84%)

USD 0.88B
HCSG Healthcare Services Group Inc

-0.17 (-1.69%)

USD 0.74B
CMPS Compass Pathways Plc

-0.11 (-1.77%)

USD 0.47B

ETFs Containing ENSG

OSCV 2.67 % 0.79 %

N/A

N/A
JSMD Janus Henderson Small/Mid.. 1.72 % 0.50 %

-0.84 (-0.99%)

USD 0.38B
VIOG Vanguard S&P Small-Cap 60.. 1.15 % 0.20 %

-1.15 (-0.99%)

USD 0.98B
OASC OneAscent Small Cap Core .. 1.06 % 0.00 %

-0.27 (-0.99%)

N/A
MWON:XETRA Amundi S&P SmallCap 600 E.. 0.99 % 0.00 %

-0.19 (-0.99%)

USD 0.22B
USASUS:SW Amundi S&P SmallCap 600 E.. 0.99 % 0.00 %

-0.04 (-0.99%)

USD 0.22B
CBUSAS:SW Amundi S&P SmallCap 600 E.. 0.85 % 0.00 %

N/A

N/A
IDP6:SW iShares S&P SmallCap 600 .. 0.66 % 0.00 %

-0.52 (-0.99%)

USD 2.03B
SPSM SPDR® Portfolio S&P 600 .. 0.62 % 0.06 %

-0.45 (-0.99%)

USD 11.77B
VTWG Vanguard Russell 2000 Gro.. 0.62 % 0.20 %

-2.27 (-0.99%)

USD 0.99B
ZSML-F:CA BMO S&P US Small Cap Inde.. 0.61 % 0.00 %

N/A

CAD 5.46M
ZSML-U:CA BMO S&P US Small Cap Inde.. 0.61 % 0.00 %

N/A

N/A
RTWO:LSE L&G Russell 2000 US Small.. 0.55 % 0.00 %

+0.03 (+-0.99%)

USD 0.15B
RTWP:LSE Legal & General UCITS ETF.. 0.55 % 0.00 %

+2.00 (+-0.99%)

USD 0.15B
R2SC:LSE SPDR® Russell 2000 US Sm.. 0.31 % 0.00 %

+0.04 (+-0.99%)

USD 3.34B
R2US:LSE SPDR® Russell 2000 US Sm.. 0.31 % 0.00 %

-0.01 (-0.99%)

USD 3.34B
R2US:SW SPDR® Russell 2000 US Sm.. 0.31 % 0.00 %

-0.29 (-0.99%)

USD 3.30B
XRSG:LSE Xtrackers Russell 2000 UC.. 0.31 % 0.00 %

+18.00 (+-0.99%)

USD 1.37B
XRSU:LSE Xtrackers Russell 2000 UC.. 0.31 % 0.00 %

-0.52 (-0.99%)

USD 1.37B
XRS2:SW Xtrackers Russell 2000 UC.. 0.31 % 0.00 %

-2.10 (-0.99%)

USD 1.37B
VTWO Vanguard Russell 2000 Ind.. 0.31 % 0.15 %

-0.69 (-0.99%)

USD 11.59B
RSSL Global X Funds 0.30 % 0.00 %

-0.70 (-0.99%)

N/A
DFAS Dimensional U.S. Small Ca.. 0.29 % 0.00 %

-0.45 (-0.99%)

USD 8.87B
UWM ProShares Ultra Russell20.. 0.24 % 0.95 %

-0.70 (-0.99%)

USD 0.29B
HDG ProShares Hedge Replicati.. 0.00 % 0.95 %

-0.06 (-0.99%)

USD 0.03B
IWO iShares Russell 2000 Grow.. 0.00 % 0.24 %

-2.70 (-0.99%)

N/A
OLD 0.00 % 0.50 %

N/A

N/A
KSCD 0.00 % 0.00 %

N/A

N/A
XSMO Invesco S&P SmallCap Mome.. 0.00 % 0.39 %

-0.58 (-0.99%)

USD 1.04B
VRTGX Vanguard Russell 2000 Gro.. 0.00 % 0.00 %

-0.63 (-0.99%)

USD 1.19B
VRTIX Vanguard Russell 2000 Ind.. 0.00 % 0.00 %

-3.02 (-0.99%)

USD 10.02B
SLY 0.00 % 0.15 %

N/A

N/A
SLYG SPDR® S&P 600 Small Cap .. 0.00 % 0.15 %

-0.89 (-0.99%)

N/A
URTY ProShares UltraPro Russel.. 0.00 % 0.95 %

-1.25 (-0.99%)

USD 0.46B
VIOO Vanguard S&P Small-Cap 60.. 0.00 % 0.15 %

-0.99 (-0.99%)

N/A
IDP6:LSE iShares S&P SmallCap 600 .. 0.00 % 0.00 %

-0.07 (-0.99%)

N/A
R2US:PA SSgA SPDR ETFs Europe II .. 0.00 % 0.00 %

-0.10 (-0.99%)

USD 3.34B
IUS3:F iShares S&P Small Cap 600.. 0.00 % 0.00 %

-0.60 (-0.99%)

N/A
XRS2:F Xtrackers (IE) Public Lim.. 0.00 % 0.00 %

+3.75 (+-0.99%)

USD 1.19B
ZPRR:F SSgA SPDR ETFs Europe II .. 0.00 % 0.00 %

+0.82 (+-0.99%)

USD 2.91B
ETLZ:XETRA L&G Russell 2000 US Small.. 0.00 % 0.00 %

-0.21 (-0.99%)

USD 0.09B
IUS3:XETRA iShares S&P Small Cap 600.. 0.00 % 0.00 %

-0.19 (-0.99%)

N/A
XRS2:XETRA Xtrackers Russell 2000 UC.. 0.00 % 0.00 %

-0.70 (-0.99%)

USD 1.19B
ZPRR:XETRA SPDR® Russell 2000 US Sm.. 0.00 % 0.00 %

-0.19 (-0.99%)

USD 2.91B
ZSML:CA BMO S&P US Small Cap Inde.. 0.00 % 0.00 %

+0.01 (+-0.99%)

N/A
SMLE 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Medical Care Facilities) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -36.07% 41% F 22% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -36.07% 41% F 22% F
Trailing 12 Months  
Capital Gain -23.93% 41% F 26% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -23.93% 41% F 26% F
Trailing 5 Years  
Capital Gain 83.14% 73% C 74% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 83.14% 73% C 74% C
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization 8.23B 100% F 92% A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.